Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

Harmony Biosciences (NASDAQ:HRMY) reported third-quarter net revenue of $269 million, up from $239 million a year earlier, as demand for its narcolepsy treatment WAKIX continued to grow. The company...

Harmony Biosciences Q3 Earnings Call Highlights ↗

November 04, 2026

Harmony Biosciences Holdings (NASDAQ:HRMY) Q3 2026 Earnings Miss Overshadows WAKIX Growth ↗

Performance

52-Week Range 22.2% below 52-week high

33.84

25.9052W Low 43.4952W High

1 Week 13.7% below 1-week high

32.611W Low 39.201W High

Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) traded between $25.90 and $43.49 over the past 52 weeks and last traded at $33.84, 22.2% below its 52-week high. Over the past week it ranged between $32.61 and $39.20.

Past 12 Months

-12.3%

-15.2%

-11.5%

+3.2%

-9.5%

+10.2%

1W -$4.75

1M -$6.08

3M -$4.40

6M +$1.06

YTD -$3.54

1Y +$3.12

HRMY was +10.2% over the past year, +3.2% over six months, -9.5% year to date, -12.3% in the last week.

12 Months vs Market

HRMY

+10.2%

DIA

+9.9%

SPY

+9.3%

QQQ

+5.6%

IWM

+12.7%

Over the past 12 months HRMY returned +10.2% versus DIA (Dow) +9.9%, SPY (S&P 500) +9.3%, QQQ (Nasdaq 100) +5.6% and IWM (Russell 2000) +12.7%.

Volume & Liquidity 0.30× 3-mo avg

Today 289,417 3-mo avg 977.6K

1.3M

1.1M

977.6K

917.5K

YTD

897.3K

878.5K

HRMY most recently traded 289,417 shares against a 3-month average daily volume of 977.6K.

More News

November 04, 2026

Via Chartmill

Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile

November 04, 2026

Harmony Biosciences Holdings (NASDAQ:HRMY): A Value Stock with Strong Financial Health ↗

July 11, 2026

Via Chartmill

Harmony Biosciences Holdings (NASDAQ:HRMY) Q1 Revenue Meets Guidance, But EPS Miss and Elevated Spending Weigh on Shares ↗

May 07, 2026

Via Chartmill

4 Small-Cap Stocks With Paths to Recovery After the Fed's September Rate Hike ↗

October 26, 2026

Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026

October 20, 2026

Why Harmony Biosciences Stock Got Mashed on Monday ↗

October 12, 2026

Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth

October 12, 2026

Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days

October 01, 2026

Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress

September 03, 2026

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

August 27, 2026

Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline ↗

August 14, 2026

Harmony Biosciences (HRMY) Q2 2026 Earnings Call Transcript ↗

August 11, 2026

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium

August 06, 2026

Harmony Biosciences Q2 Earnings Call Highlights ↗

August 04, 2026

Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile

August 04, 2026

Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026

July 21, 2026

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition

July 16, 2026

From Harmony Biosciences Holdings, Inc.

Via Business Wire

Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting

June 11, 2026

From Harmony Biosciences Holdings, Inc.

Via Business Wire

Harmony (HRMY) Q1 2026 Earnings Transcript ↗

June 01, 2026

Harmony Biosciences to Participate in Upcoming Investor Conferences

May 27, 2026

From Harmony Biosciences Holdings, Inc.

Via Business Wire

A Healthcare Fund Just Made Bitgo Its Biggest Bet ↗

May 19, 2026

A beaten-down biotech just lost a meaningful backer — should you care? ↗

May 19, 2026